Truvestments Capital’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.2K Hold
1,183
0.01% 577
2025
Q4
$20K Hold
1,183
﹤0.01% 592
2025
Q3
$25.7K Hold
1,183
﹤0.01% 548
2025
Q2
$16.9K Hold
1,183
﹤0.01% 563
2025
Q1
$15.4K Hold
1,183
﹤0.01% 594
2024
Q4
$15.8K Hold
1,183
﹤0.01% 528
2024
Q3
$7.1K Buy
+1,183
New +$5K ﹤0.01% 632
2024
Q2
Sell
-1,848
Closed -$6.93K 380
2024
Q1
$6.93K Hold
1,848
﹤0.01% 523
2023
Q4
$8.09K Hold
1,848
﹤0.01% 534
2023
Q3
$7.71K Hold
1,848
﹤0.01% 470
2023
Q2
$6.45K Hold
1,848
﹤0.01% 503
2023
Q1
$7.12K Buy
+1,848
New +$6.74K ﹤0.01% 472

Other funds holding ETON

Truvestments Capital's ETON Position: Q1 2026 in Review

Truvestments Capital held its Eton Pharmaceutcials (ETON) position steady in Q1 2026 at 1,183 shares worth $29.2K. The position accounts for 0.01% of the portfolio, ranked #577.

Truvestments Capital first reported a position in ETON in Q1 2023 and has held it in 12 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Truvestments Capital held 1,183 shares of Eton Pharmaceutcials worth $29.2K as of Q1 2026.
  • Truvestments Capital left its Eton Pharmaceutcials share count unchanged in Q1 2026.
  • Eton Pharmaceutcials made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #577 holding.
  • Truvestments Capital first reported a position in Eton Pharmaceutcials in Q1 2023 and has held it in 12 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.